K.U.Leuven
  Search for Staff Students Organisational chart Search matrix Keywords

Experimental Genetics Group

Bolleke Abstract   Pijltje
Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology.

Rev Neurol (Paris). 2006 Oct;162(10):903-7.

Muyllaert D, Terwel D, Borghgraef P, Devijver H, Dewachter I, Van Leuven F.

Experimental Genetics Group, LEGT-EGG, KULeuven, Campus Gasthuisberg, Leuven, Belgium.

Describing and understanding the pathological processes which devastate the brain of Alzheimer's disease (AD) patients remains a major target for experimental biology. We approached this problem by generating different types of single and double transgenic mice that develop pathological hallmarks of AD. In APP-V717 mice, the progression from intracellular amyloid to diffuse and senile plaques with vascular deposits, is preceded by early defects in cognition and LTP. In Tau-P301L mice, the morbid tauopathy with intracellular filaments, cause mortality before age 1 year. Ageing APP-V717IxTau-P301L double tg mice (14-17 months) have combined AD-like pathology in hippocampus and cortex consisting of amyloid plaques and neurofibrillary tangles. Remarkably, while Tau-P301L mice die before age 1 year, the APP-V717IxTau-P301L double tg mice survive much longer, which correlates with alleviation of tauopathy in hindbrain, despite aggravation in forebrain. This hypothesis is corroborated in Tau-P301LxGSK-3B double transgenic mice, which have also an extended lifespan relative to Tau-P301L mice, that correlates with reduction of brainstem tauopathy. At the same time, Tau-P301LxGSK-3B mice have dramatic forebrain tauopathy, with "tangles in almost all neurons", although without hyper-phosphorylation of Tau. The data corroborate the hypothesis that GSK-3B is the missing link between the amyloid and tau-pathology, and position GSK-3B as prominent player in the pathogenesis in AD.

pdf FULL TEXT
K.U.Leuven - CWIS Copyright © Katholieke Universiteit Leuven | Comments on the content: Fred Van Leuven
Production:Annick Vogels| Most recent update: October 21, 2009 | Disclaimer
URL: http://med.kuleuven.be/legtegg/